Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01466218 · ClinicalTrials.gov registry record

World Trade Center (WTC) CHEST

A clinical trial of Obstructive Sleep Apnea and Cardiovascular Disease, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
1,012
Enrollment target
1
Study location

NCT01466218 is a study of Obstructive Sleep Apnea and Cardiovascular Disease that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,012 participants, above the 215-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (371% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01466218, a study of Obstructive Sleep Apnea and Cardiovascular Disease, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
1,012 participants
Enrollment target
1
Study location

Study Summary

This project will evaluate the effects of World Trade Center (WTC) exposure in WTC responders 10-13 years following the events of 9/11. Prior studies have described persistent pulmonary function abnormalities in a significant portion of responders. The investigators study seeks to examine the relationship between pulmonary function abnormalities and other markers of chronic cardiopulmonary disease and further elucidate the pathophysiologic effects of exposure to inhaled particulate matter (PM) on 9/11. This study will provide critical information regarding risk of exposure to PM, risk factors for disease and potential for improvements in diagnosis and treatment.

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 1,012 participants
Start Date 2011-11
Est. Completion 2014-06

What the Registry Record Tells You About NCT01466218

The ClinicalTrials.gov registry entry for NCT01466218 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,012 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 215-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (371% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.

NCT01466218 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01466218 about?

NCT01466218 is a clinical study titled "World Trade Center (WTC) CHEST". This project will evaluate the effects of World Trade Center (WTC) exposure in WTC responders 10-13 years following the events of 9/11. Prior studies have described persistent pulmonary function abnormalities in a significant portion of responders. The investigators study seeks to examine the relati...

What is the current status of trial NCT01466218?

This trial is currently completed. The enrollment target is 1,012 participants. The study started on 2011-11. Estimated completion is 2014-06.

What conditions does trial NCT01466218 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Cardiovascular Disease, Cardiac Disease, Pulmonary Disease, Cardiopulmonary Disease.

Who is sponsoring clinical trial NCT01466218?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01466218 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.